Trial | NCT00595543  Report issue

Title

Treatment of Acute Pseudophakic Cystoid Macular Edema: Bromfenac 0.09% Versus Diclofenac Sodium 0.1% Versus Ketorolac Tromethamine 0.5%

  • Phase

    Phase 4

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    166
To compare bromfenac 0.09%, diclofenac sodium 0.1%, and ketorolac tromethamine 0.5% ophthalmic solutions for the treatment of acute pseudophakic CME after cataract surgery.
Study Started
Jan 31
2008
Primary Completion
Mar 31
2009
Study Completion
Mar 31
2009
Last Update
Mar 19
2009
Estimate

Drug Bromfenac

1 drop (in the eye) Instill one drop in the affected eye twice daily for three months

Drug Ketorolac

1 drop (in the eye) Instill one drop in the affected eye four times daily for three months

Drug Diclofenac

1 drop (in the eye) Instill one drop in the affected eye four times daily for three months

1 Active Comparator

2 Active Comparator

3 Active Comparator

Criteria 

Inclusion Criteria:

Patients must be diagnosed with acute pseudophakic CME within 12 months of cataract surgery
Males and females 18 years and older
Able to provide written informed consent

Exclusion Criteria:

Complicated cataract surgery, particularly posterior capsule rupture and vitreous loss
Pre-Existing macular pathology, including macular edema, macular scar, macular hole, or macular pucker
History of Uveitis
Ipsilateral intraocular surgery prior to cataract surgery
CME greater than one year duration
No Results Posted